TNF Blockade Reduces Prostatic Hyperplasia and Inflammation while Limiting BPH Diagnosis in Patients with Autoimmune Disease
R. E. Vickman, L. Aaron-Brooks, R. Zhang, N. A. Lanman, B. Lapin, V. Gil, M. Greenberg, T. Sasaki, G. M. Cresswell, M. M. Broman, J. Petkewicz, P. Talaty, B. T. Helfand, A. P. Glaser, C.-H. Wang, , S. W. Hayward
Patient data and mouse models suggest that repurposing tumor necrosis factor alpha blockade reduces inflammation-mediated prostatic hyperplasia.
bioRxiv · Mar 11, 2021Cell Biology